The synergistic antitumor effect of combination therapy with a MEK inhibitor and YAP inhibitor on pERK-positive neuroblastoma

M Takemoto, T Tanaka, R Tsuji, Y Togashi… - Biochemical and …, 2021 - Elsevier
Background We previously reported the in vitro and in vivo antitumor effects of trametinib, a
MEK inhibitor, on neuroblastoma with MAPK pathway mutations. As we observed eventual …
被引用次数：9 相关文章

The synergistic antitumor effect of combination therapy with a MEK inhibitor and YAP inhibitor on pERK-positive neuroblastoma

M Takemoto, T Tanaka, R Tsuji… - Biochemical and …, 2021 - pubmed.ncbi.nlm.nih.gov
Background We previously reported the in vitro and in vivo antitumor effects of trametinib, a
MEK inhibitor, on neuroblastoma with MAPK pathway mutations. As we observed eventual …

[引用][C] The synergistic antitumor effect of combination therapy with a MEK inhibitor and YAP inhibitor on pERK-positive neuroblastoma

M Takemoto, T Tanaka, R Tsuji, Y Togashi… - Biochemical and …, 2021 - cir.nii.ac.jp
The synergistic antitumor effect of combination therapy with a MEK inhibitor and YAP
inhibitor on pERK-positive neuroblastoma | CiNii Research CiNii 国立情報学研究所 学術情報 …

The synergistic antitumor effect of combination therapy with a MEK inhibitor and YAP inhibitor on pERK-positive neuroblastoma.

M Takemoto, T Tanaka, R Tsuji, Y Togashi… - Biochemical and …, 2021 - europepmc.org
Background We previously reported the in vitro and in vivo antitumor effects of trametinib, a
MEK inhibitor, on neuroblastoma with MAPK pathway mutations. As we observed eventual …

The synergistic antitumor effect of combination therapy with a MEK inhibitor and YAP inhibitor on pERK-positive neuroblastoma

M Takemoto, T Tanaka, R Tsuji… - Biochemical and …, 2021 - kyushu-u.elsevierpure.com
Background: We previously reported the in vitro and in vivo antitumor effects of trametinib, a
MEK inhibitor, on neuroblastoma with MAPK pathway mutations. As we observed eventual …

[引用][C] The synergistic antitumor effect of combination therapy with a MEK inhibitor and YAP inhibitor on pERK-positive neuroblastoma

M Takemoto, T Tanaka, R Tsuji, Y Togashi, M Higashi… - 2021